Skip to main navigation Skip to search Skip to main content

How to define a quadruple aim framework to assess value in critical pathway of the patients with Clostridioides difficile infection

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: The study aims to define the set of Key Performance Indicators (KPIs) required to assess the Value delivered by managing patients with Clostridioides difficile infection through a Critical Pathway. We used the quadruple aim Value-Based approach, and we validated the set of KPIs with the Delphi method. MATERIALS AND METHODS: The study focuses on patients on board a Critical Pathway on Clostridioides difficile Infection and targeted towards a Fecal Microbiota Transplantation (FMT). FMT has been used to successfully treat recurrent Clostridium difficile infection. A two-round e-Delphi survey collecting data was conducted in 2019-2020 to validate the Value-Based evaluation tool. The Value-Based criteria taken into account are Clinical Outcomes, Experience of Care, Per-capita cost, Physician's burnout. RESULTS: The two rounds led to the validation of 50 items, and four primary clinical outcomes (Mortality rate, length of stay, readmission and complications related to the illness). CONCLUSIONS: The evaluation tool included is validated in its totality and can provide a comprehensive overview of the Value created by the Critical pathway for patients with Clostridioides difficile. We can extend the approach illustrated in this study can also to evaluate other Critical pathways.
Original languageEnglish
Pages (from-to)4597-4610
Number of pages14
JournalEuropean Review for Medical and Pharmacological Sciences
Volume25
Issue number13
DOIs
Publication statusPublished - 2021

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Keywords

  • Clostridioides difficile
  • Delphi
  • Fecal microbiota transplantation
  • Key performance indicator
  • PCA/PDTA implementation
  • Value-based

Fingerprint

Dive into the research topics of 'How to define a quadruple aim framework to assess value in critical pathway of the patients with Clostridioides difficile infection'. Together they form a unique fingerprint.

Cite this